Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 6:55 pm Purchase | 2025-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Novo Holdings A/S | 3,650,737 6.400% | 475,737 (+14.98%) | Filing History |
| 2026-02-17 4:15 pm Purchase | 2025-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | RA Capital Management, L.P. | 5,713,852 9.900% | 1,148,985 (+25.17%) | Filing History |
| 2026-02-17 4:12 pm Purchase | 2025-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | BIOTECHNOLOGY VALUE FUND L P | 5,847,281 9.990% | 1,214,532 (+26.22%) | Filing History |
| 2026-02-17 12:42 pm Purchase | 2025-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | JANUS HENDERSON GROUP PLC JHG | 4,635,875 8.100% | 2,383,635 (+105.83%) | Filing History |
| 2026-02-09 4:05 pm Sale | 2025-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | GOLDMAN SACHS GROUP INC GS | 4,286,077 7.500% | -137,358 (-3.11%) | Filing History |
| 2025-10-20 5:12 pm Purchase | 2025-10-13 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Novo Holdings A/S | 3,175,000 6.800% | 3,175,000 (New Position) | Filing History |
| 2025-10-17 6:13 pm Sale | 2025-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT | BlackRock Inc. BLK | 3,062,596 6.600% | -552,720 (-15.29%) | Filing History |
| 2025-05-15 5:44 pm Sale | 2025-03-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Venrock Healthcare Capital Partners III, L.P. | 677,600 1.500% | -2,274,771 (-77.05%) | Filing History |
| 2025-05-15 4:29 pm Sale | 2025-03-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | BIOTECHNOLOGY VALUE FUND L P | 4,632,749 9.990% | -201,548 (-4.17%) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | BlackRock Inc. BLK | 3,615,316 7.800% | -1,349,703 (-27.18%) | Filing History |
| 2025-02-14 6:30 pm Sale | 2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | RA Capital Management, L.P. | 4,564,867 9.900% | -533,344 (-10.46%) | Filing History |
| 2025-02-14 6:09 pm Sale | 2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Venrock Healthcare Capital Partners III, L.P. | 2,952,371 6.400% | -1,447,629 (-32.90%) | Filing History |
| 2025-02-14 4:20 pm Sale | 2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | BIOTECHNOLOGY VALUE FUND L P | 4,834,297 9.990% | -2,548,345 (-34.52%) | Filing History |
| 2025-02-14 11:34 am Sale | 2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | JANUS HENDERSON GROUP PLC JHG | 2,252,240 4.900% | -884,847 (-28.21%) | Filing History |
| 2025-02-14 08:40 am Sale | 2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Deep Track Capital, LP | 609,900 1.320% | -3,486,552 (-85.11%) | Filing History |
| 2025-02-10 5:28 pm Purchase | 2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | GOLDMAN SACHS GROUP INC GS | 4,423,435 9.600% | 831,575 (+23.15%) | Filing History |
| 2024-12-06 4:28 pm Purchase | 2024-11-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT | BlackRock Inc. BLK | 4,965,019 10.700% | 96,230 (+1.98%) | Filing History |
| 2024-11-15 5:05 pm Sale | 2024-11-13 | 13G | 4D Molecular Therapeutics, Inc. FDMT | RA Capital Management, L.P. | 5,098,211 11.000% | -103,934 (-2.00%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT | RA Capital Management, L.P. | 5,202,145 9.990% | 1,038,934 (+24.96%) | Filing History |
| 2024-11-14 4:31 pm Sale | 2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT | VIKING GLOBAL INVESTORS LP | 0 0.000% | -4,247,914 (Position Closed) | Filing History |